PDPK1 and breast cancer: EV-delivered miR-181c from breast cancer cells downregulates 3-phosphoinositide-dependent protein kinase-1 (PDPK1) and disrupts the blood-brain barrier and consists of tight junctions between ECs and surrounding cells that contribute to low permeability and promote cancer metastasis in distant organs (Tominaga et al., 2015b).